CT and MRI in Advanced Ovarian Cancer: Advances in Imaging Techniques

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Ovarian cancer (OC) is a leading cause of gynecologic cancer mortality, frequently presenting with advanced, disseminated disease.
• Despite current treatments, a significant percentage of high-grade serous OC cases experience early relapse even after optimal primary therapy.
• Current imaging modalities have limitations in detecting small-volume disease and predicting treatment response.

Purpose of the Study:

• To explore the role of advanced imaging techniques, including contrast-enhanced CT (CE-CT), MRI, and radiomics, in evaluating and managing advanced ovarian cancer.
• To assess the potential of integrating these imaging modalities for improved surgical planning and patient prognosis.

Main Methods:

• Review of advances in contrast-enhanced CT (CE-CT) and MRI for ovarian cancer staging and assessment.
• Discussion of the utility of diffusion-weighted imaging and gadolinium-enhanced MRI in detecting peritoneal disease.
• Exploration of radiomics for extracting quantitative features from imaging data to predict treatment response and recurrence risk.

Main Results:

• CT is effective for staging and assessing tumor extent but less sensitive for small peritoneal deposits.
• MRI offers superior soft-tissue contrast for detailed peritoneal disease evaluation and mass characterization.
• Radiomics shows promise in personalizing treatment and identifying high-risk patients, though its predictive capabilities for treatment response and prognosis require further validation.

Conclusions:

• The integration of CT, MRI, and radiomics holds significant potential for enhancing surgical planning in advanced ovarian cancer.
• This multimodal imaging approach could lead to improved long-term survival outcomes for patients with advanced OC.
• Further research is needed to fully leverage radiomics for predicting treatment response and prognosis in ovarian cancer.